We found that ubiquitous overexpression of ImpL2 was sufficient to block insulin signalling (as measured by Akt phosphorylation) (Fig. 1H) and to prevent that infection-mediated increase in TOR signalling, as measured by S6K phosphorylation (Fig. 1H). The gene discussed is AKT1; the disease is infection.